PEGylated Drug Molecule Technology for Long-acting Controlled-release Injection

CD Formulation offers polyethylene glycol modified drug molecule technology, where covalent attachment of PEG to macromolecules can reduce immunogenicity, improve solubility and bioavailability, and increase anti-protein hydrolysis, while also extending half-life.

• Supplier: CD Formulation
• Product #: S-MSMN-042